Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94662Review ArticleTreatment of cognitive disorders in patients with chronic cerebral ischemiaSolovevaE. Yuellasolovieva@ya.ruN.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation19022017192-271228122021Copyright © 2017, Consilium Medicum2017The article discusses the concept of chronic cerebral insufficiency failure, manifested by a progressive multifocal disorder of brain functions of varying severity, the results of experimental and clinical studies of the extract of ginkgo biloba, which proved the possibility of the drug to quickly and effectively influence the various links in the pathogenesis of cognitive impairment.chronic cerebral ischemiacognitive disordersmemoryhigher mental functionsхроническая ишемия мозгакогнитивные расстройствапамятьвысшие психические функции[Федин А.И., Румянцева С.А. Избранные вопросы базисной интенсивной терапии нарушений мозгового кровообращения. М.: Интермедика, 2002.][Верещагин Н.В., Пирадов М.А., Суслина З.А. Инсульт: принципы диагностики, лечения и профилактики. М.: Интермедика, 2002.][Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М., 2001; с. 45-98.][Дамулин И.В. Сосудистые когнитивные нарушения: клинические и терапевтические аспекты. Рус. мед. журн. 2006; 14 (9): 658-64.][Захаров В.В. Умеренные когнитивные расстройства. Диагностика и лечение. Рус. мед. журн. 2006; 14 (9): 685-8.][Маньковский Б.Н., Слонимская В.М. Гипертонические энцефалопатии. Врачебное дело. 1959; 7.][Скворцова В.И. Нейропротективная стратегия ишемического инсульта. Врач. 2004; 6: 26-32.][Chui et al. Clinical Criteria for the Diagnosis of Vascular Dementia: A Multicenter Study of Comparability and Interrater Reliability. Arch Neurol 2000; 57: 191-6.][Roman G.C, Tatemichi T.K, Erkinjuntti T et al. Vascular dementia - diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. J Neurology 1993; 43: 250-60.][Gupta C.M. Phospholipids in disease. In : Phospholipids Handbook, 1993; p. 895-905.][Mairs I, Marocci L, Droy-Lefaix M.T et al. Peroxyl radical scavenging activity of Ginkgo biloba extract Egb 761. Biochem Pharmacol 1995; 49: 1649-55.][Bridi R, Crossetti F.P, Steffen V.M et al. The antioxidant activity of standartized extract of Ginkgo biloba (Egb 761) in rats. Phytother Res 2001; 15: 449-51.][Pardon M.C, Joubert C, Perz-Diaz F et al. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long - term treatment with Ginkgo biloba extract (EGb 761). Mech Ageing Dev 2000; 13: 157-68.][Tchantchou F, Xu Y, Wu Y et al. EGb 761 enhances adult hippocampal neurogenesis and phosphorilation of CREB in transgenic mouse model of Alzheimer’s disease. FASEB J 2007; 21: 2400-8.][Timiras P.S. Physiological Basis of Aging and Geriatrics. N.Y.: CRC Press, 2003.][Kristofikova Z, Benesova O, Tejkalova H. Changes of high - affinity choline uptake in the hippocampus of old rats after long - term administration of two nootropic drugs (Tacrine and Ginkgo biloba extract). Dementia 1992; 3: 304-7.][Huquet F, Drieu K, Piriou K. Decreased cerebral 5-HT 1a receptors during aging: reversal by Ginkgo biloba extract (Egb 761). J Pharm Pharmacol 1994; 46: 316-8.][Williams B, Watanabe C, Schultz P. Age - related effects of Ginkgo biloba extract on synaptic plasticity and excitability. Neurobiol Aging 2004; 25 (7): 955-62.][Stoll S, Scheuer K, Pohl O et al. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 1996; 29: 144-9.][Sun B, Hu Y, Yuan H et al. Extract of Ginkgo biloba promotes the expression of VEGF followed subarachnoid hemorrhage in rats. Int J Neurosci 2009; 119: 995-1005.][Yao Z.X, Han Z, Drieu K, Papadopoulos V.J. Ginkgo biloba extract (Egb 761) inhibits beta - amyloid production by lowering free cholesterol levels. Nutr Biochem 2004; 15 (12): 749-56.][Andrieu S, Ousset P.J, Coley N et al. GuidAge study GROUP. Curr Alzheimer Res 2008; 5 (4): 406-15.][Vellas B, Andrieu S, Ousset P.J. Methodological issues. A 5-year double - blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology 2006; 67 (9): S6-S11.][De Kosky S.T, Fitzpatrick A, Ives D.G. The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extracts in prevention of dementia. Contemporary Clinicals Trials 2006; 27: 238-53.][Le Bars P.L, Katz M.M, Berman N et al. A placebo - controlled, double - blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278: 1327-32.]